BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu GF, Tang D, Li P, Wang S, Xu YX, Long AH, Zhou NL, Zhang LL, Chen J, Xiang XX. S-1-based combination therapy vs S-1 monotherapy in advanced gastric cancer: A meta-analysis. World J Gastroenterol 2014; 20(1): 310-318 [PMID: 24415887 DOI: 10.3748/wjg.v20.i1.310]
URL: https://www.wjgnet.com/1007-9327/full/v20/i1/310.htm
Number Citing Articles
1
YAN HOU, JUNWEN ZHEN, XIAODONG XU, KUN ZHEN, BIN ZHU, RUI PAN, CHIDONG ZHAO. miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancerOncology Letters 2015; 10(4): 1985 doi: 10.3892/ol.2015.3587
2
Ning-ning Bian, Yong-hong Wang, Guang-tao Min. S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysisInternational Journal of Surgery 2019; 62: 34 doi: 10.1016/j.ijsu.2018.11.010
3
Fabiana G. Curea, Mohamed Hebbar, Silvia M. Ilie, Xenia E. Bacinschi, Oana G. Trifanescu, Inga Botnariuc, Rodica M. Anghel. Current Targeted Therapies in HER2-Positive Gastric AdenocarcinomaCancer Biotherapy and Radiopharmaceuticals 2017; 32(10): 351 doi: 10.1089/cbr.2017.2249
4
Yuan Zhang, Jiangang Wang, Wenzhi An, Chen Chen, Wencheng Wang, Chao Zhu, Fangzhou Chen, Huizhao Chen, Wei Zheng, Jie Gong. MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in GliomaTechnology in Cancer Research & Treatment 2019; 18: 153303381985413 doi: 10.1177/1533033819854132
5
Qian Zhang, Qinghua Zhang, Hui Yan, Yanjie You, Juan Cao, Wenfan Wang, Dan Zhao, Xiaoxu Zhang, Jing Wu, Zhiqiang Chen, Wenjun Yang. Survival Advantages in Gastric Cancer Patients Receiving Preoperative SOX Regimen ChemotherapyCancer Biotherapy and Radiopharmaceuticals 2023; 38(2): 81 doi: 10.1089/cbr.2020.3970
6
Yue Zhao, Wangqing Chen, Wu Zhu, Jie Li, Juan Su, Shuang Zhao, Mingliang Chen, Jianglin Zhang, Aiyuan Guo, Siyu Yan, Xingchen Zhou, Xinwei Kuang, Zhaoqian Liu, Dan Luo, Todd C Knepper, Yijing He, Xiang Chen. Tandem repeats of TSER significantly influence the efficacy of 5-fluorouracil in the treatment of plantar wartsPersonalized Medicine 2016; 13(3): 233 doi: 10.2217/pme-2015-0014
7
Fang-Lan Wu, De-Cheng Lu, Yan-Ping Ying, Jin-Jiao Huang, Ai-Min Zhou, Dun-Ke Jiang, Mao-Wei Chen, Xi Yang, Jia Zhou, Hui-Qiao Huang, Hong-Yan Zeng. A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric CancerMedicine 2015; 94(16): e652 doi: 10.1097/MD.0000000000000652
8
Deng-Yan Zhu, Xiang-Nan Li, Yu Qi, Dong-Lei Liu, Yang Yang, Jia Zhao, Chun-Yang Zhang, Kai Wu, Song Zhao. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTENBiomedicine & Pharmacotherapy 2016; 81: 79 doi: 10.1016/j.biopha.2016.03.029
9
Zhu Li, Xu Hou, Juan Chen, Huidong Sun, Yuetang Mi, Yongling Sui, Yuhong Li, Jiaping Xie, Yingli Qiao, Xiaofeng Lei, Xiaoshuang Che, Jun Liu. Efficacy and safety of SOX chemotherapy with or without surgery in AFP-producing advanced gastric cancerOncology Letters 2017; 14(1): 579 doi: 10.3892/ol.2017.6240
10
Jin Xiao. MiR-32 Functions as a Tumor Suppressor and Directly Targets EZH2 in Human Oral Squamous Cell CarcinomaMedical Science Monitor 2014; 20: 2527 doi: 10.12659/MSM.892636
11
Changshan Song, Pingfang Lu, Weicheng Shi, Guoqiang Sun, Guangsuo Wang, Xujie Huang, Zheng Wang, Zhigang Wang. MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinomaBiomedicine & Pharmacotherapy 2016; 83: 843 doi: 10.1016/j.biopha.2016.07.036
12
Hiromi Nagano, Yuichi Kurono, Kakushi Matushita. Adult T-cell leukemia/lymphoma in patients with head and neck cancer after S-1 chemotherapyAuris Nasus Larynx 2017; 44(2): 195 doi: 10.1016/j.anl.2016.05.002
13
Jinping Sun, Zheng Ren, Xinfang Sun, Hongtao Hou, Ke Li, Quanxing Ge. Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysisOncotarget 2017; 8(24): 39673 doi: 10.18632/oncotarget.17784
14
Dongsheng Zhao, Rencong Wang, Junkang Fang, Xituan Ji, Juan Li, Xiaoyan Chen, Gangfeng Sun, Zhengjun Wang, Weiping Liu, Yangang Wang, Guang Cheng, Haining Zhen, Chunhua Sun, Zhou Fei. RETRACTED ARTICLE: MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5aMolecular Neurobiology 2017; 54(4): 2823 doi: 10.1007/s12035-016-9867-5
15
Emil ter Veer, Nadia Haj Mohammad, Paul Lodder, Lok Lam Ngai, Mary Samaan, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven. The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysisGastric Cancer 2016; 19(3): 696 doi: 10.1007/s10120-015-0587-8
16
S.M.Zeeshan Qadar, Zhiyong Dong, Sheikh Mohammed Shariful Islam, Jianxue Wang, Xiling Xu, Fakhsheena Anjum, Sana Shamim, Bafreen Sherif, Sundas Ali. S-1 plus oxaloplatin (S-1OX) versus capecitabine plus oxaloplatin (CAPOX) for advanced gastric cancer: A systematic review and meta-analysisComputer Methods and Programs in Biomedicine Update 2024; 5: 100151 doi: 10.1016/j.cmpbup.2024.100151
17
Xiaolong Qi, Yanna Liu, Wei Wang, Danxian Cai, Wende Li, Jialiang Hui, Chuan Liu, Yanxia Zhao, Guoxin Li. Management of advanced gastric cancer: An overview of major findings from meta-analysisOncotarget 2016; 7(47): 78180 doi: 10.18632/oncotarget.12102
18
Yang Kai, Cheng Qiang, Pan Xinxin, Zhou Miaomiao, Lin Kuailu. RETRACTED ARTICLE: Decreased miR-154 expression and its clinical significance in human colorectal cancerWorld Journal of Surgical Oncology 2016; 13(1) doi: 10.1186/s12957-015-0607-5